Related Posts
Rhythm Pharma’s Imcivree Gets European Approval For Obesity, Control of Hunger Associated With Genetic Mutations
The European Commission (EC) has approved Rhythm Pharmaceuticals Inc’s (NASDAQ:RYTM) Imcivree (setmelanotide) for obesity and the control of hunger. The approval…
Tesla’s China Deliveries Climb To Record In June Amid Post-COVID Recovery: Report
U.S. electric vehicle giant Tesla, Inc. (NASDAQ: TSLA) reported record deliveries for June in China, as production ramped up following the COVID lockdowns.
